
July 9, 2021
Given the recent and abundant evidence that the S1 subunit of the SARS-CoV-2 spike protein damages blood vessels, is it perhaps more than likely that the spike is being cleaved and the cleaved S1 unit is attacking blood vessels?
If one notes the "side effects" of the spike protein therapies, they are PRECISELY the same as VASCULITIS:
Hay fever
Fever
Loss of appetite and weight loss
Joint and muscle pain
Fatigue
Cough Abdominal pain and gastrointestinal bleeding
Weakness, fatigue or a general feeling of being unwell
Rash or skin sores
Pain, numbness and tingling in your hands and feet
Severe abdominal pain
Shortness of breath
If the blood vessels in the heart are being attacked by the spike, this would cause Acute Coronary Syndrome. This chorus now sounds all too familiar:
Chest pain (angina) or discomfort, often described as aching, pressure, tightness or burning
Pain spreading from the chest to the shoulders, arms, upper abdomen, back, neck or jaw Nausea or vomiting
Indigestion
Shortness of breath (dyspnea)
Sudden, heavy sweating (diaphoresis)
Lightheadedness, dizziness or fainting
Unusual or unexplained fatigue
Feeling restless or apprehensive
Investigation into biomarkers for vasculitis in recipients of spike protein therapies must be done immediately. All spike protein therapies must be paused while this possibility is investigated.